Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | 10% owner | October 28, 2024 | November 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date October 28, 2024 · Filed November 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 445,933 |
Reported balance
After 2024-10-28 transaction · row 1
1 source rowRow 1 · 2024-10-28 · Sale · Disposed 1,112 · Balance 445,933 |
| Common StockSEC Table I · non-derivative | IndirectSee Fotenote | 477,972 |
Reported balance
Holding disclosure · report date 2024-10-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 477,972 F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder. |
Filing footnotes · ownership attribution and instrument terms
F1: Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2019 Filed Oct 18, 2019 20:05 UTC Amendment | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 46,700 | $0.25 | $11,903.83 |
DisclosureSEC source: 0001567619-19-019733 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,486,212 F1 · shares: The original Form 4 filed on August 23, 2019 is amended by this Form 4 to correctly reflect the number of shares acquired and the per share price for such date. F1 · price: The original Form 4 filed on August 23, 2019 is amended by this Form 4 to correctly reflect the number of shares acquired and the per share price for such date. F2 · price: This transaction was executed in multiple trades at prices ranging from $0.23 to $0.26 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Does not give effect to purchases made prior to such date and reported on Form 4 filed on October 18, 2019. Read SEC document |
| July 30, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $0.42 | $42.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 16 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770,608 Read SEC document |
| July 29, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 140,356 | $0.35 | $49,714.10 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 15 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770,508 F5 · price: This transaction was executed in multiple trades at prices ranging from $0.32 to $0.40 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 13, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 11,000 | $0.35 | $3,850.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 14 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630,152 Read SEC document |
| June 13, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.42 | $420.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 13 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,619,152 Read SEC document |
| June 12, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 25,400 | $0.36 | $9,144.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 12 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618,152 F4 · price: This transaction was executed in multiple trades at prices ranging from $0.35 to $0.49 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 10, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,500 | $0.48 | $1,200.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 11 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,592,752 Read SEC document |
| June 06, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 23,000 | $0.43 | $9,952.10 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 10 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590,252 F3 · price: This transaction was executed in multiple trades at prices ranging from $0.41 to $0.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 05, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 200 | $0.42 | $84.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 9 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,567,252 Read SEC document |
| June 05, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 500 | $0.41 | $205.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 8 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,567,052 Read SEC document |
| June 03, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.37 | $1,110.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 7 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,566,552 Read SEC document |
| June 03, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 5,000 | $0.39 | $1,950.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 6 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563,552 Read SEC document |
| May 24, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 30,000 | $0.41 | $12,159.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 5 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,558,552 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.39 to $0.42 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 5,000 | $0.54 | $2,700.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,528,522 Read SEC document |
| May 23, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.57 | $570.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523,522 Read SEC document |
| May 21, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 82,040 | $0.39 | $32,077.64 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,522,552 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.35 to $0.51 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 09, 2019 Filed Oct 18, 2019 20:11 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.40 | $400.00 |
DisclosureSEC source: 0001567619-19-019742 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440,512 Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseWarrant to acquire Common Stock · Derivative | 555,555 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · derivative · entry 15 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,555 Underlying: Common Stock · 555,555 shares Expires 2020-05-07 Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseWarrant to acquire Common Stock · Derivative | 555,556 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · derivative · entry 14 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,556 Underlying: Common Stock · 555,556 shares Expires 2024-05-07 Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,111,111 | $0.45 | $499,999.95 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 11 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,439,512 Read SEC document |
| April 25, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 20,100 | $0.65 | $13,065.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 10 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,328,401 F4 · price: This transaction was executed in multiple trades at prices ranging from $0.63 to $0.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 23, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 11,681 | $0.64 | $7,475.84 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 9 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,308,301 F3 · price: This transaction was executed in multiple trades at prices ranging from $0.64 to $0.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 22, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 39,985 | $0.64 | $25,590.40 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 8 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,296,620 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.63 to $0.65. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 18, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 84,474 | $0.63 | $53,218.62 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 7 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,256,635 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.60 to $0.63. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 09, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 100 | $0.85 | $85.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 6 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,172,161 Read SEC document |
| April 08, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 200 | $0.91 | $182.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 5 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,172,061 Read SEC document |
| April 04, 2019 Filed Dec 10, 2019 22:30 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 2,500 | $0.80 | $2,000.00 |
DisclosureSEC source: 0001567619-19-022842 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,500 F1 · ownership.nature: Owned by Fleetco, Inc. of which reporting person is sole shareholder. Read SEC document |
| March 13, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.65 | $1,950.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,171,861 Read SEC document |
| March 05, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 6,000 | $0.69 | $4,140.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168,861 Read SEC document |
| February 27, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 409 | $0.66 | $269.94 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162,861 Read SEC document |
| February 26, 2019 Filed May 9, 2019 20:37 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 1,000 | $0.68 | $680.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162,452 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.